<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Graft rejection has been a problem after bone marrow transplantation for patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="1" pm="."><plain>Ten children with SAA were conditioned for bone marrow transplantation from HLA-identical siblings, using <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (CY, 50 mg/kg) plus antithymocyte globulin (ATG, 15 mg/kg) for 4 successive days </plain></SENT>
<SENT sid="2" pm="."><plain>Marrow was infused 36 h after the last dose of CY </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> were administered as <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) prophylaxis </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients achieved durable engraftment at follow-up of 7-41+ months (mean, 25) without significant GVHD </plain></SENT>
<SENT sid="5" pm="."><plain>Since investigators have used different sources, doses, and time schedules of ATG, we compared our results with other published reports </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that CY/ATG conditioning is well tolerated and effective in children with SAA </plain></SENT>
</text></document>